You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Details for Patent: 11,993,605


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,993,605 protect, and when does it expire?

Patent 11,993,605 protects RINVOQ and is included in one NDA.

This patent has fifty patent family members in thirteen countries.

Summary for Patent: 11,993,605
Title:Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Abstract:The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis), kits, methods of synthesis, and products-by-process.
Inventor(s):Mohamed-Eslam F. Mohamed, Ahmed A. Othman, Ben Klünder, Aileen L. Pangan, Jaclyn Kay Anderson, Jeffrey W. Voss, Robert J. Padley, Heidi S. Camp
Assignee:AbbVie Inc
Application Number:US18/176,664
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,993,605: A Detailed Analysis

Introduction

When analyzing the scope and claims of a patent, such as United States Patent 11,993,605, it is crucial to delve into the intricacies of patent law, the specific claims made, and the broader patent landscape. This analysis will help in understanding the patent's validity, its protection scope, and its position within the current legal and technological context.

Patent Basics and Eligibility

To begin, it is essential to understand the fundamental principles of patent law in the United States. Patents are granted for new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof, as defined under 35 U.S.C. § 101[2].

Subject Matter Eligibility

The eligibility of a patent under § 101 is a critical aspect. The Supreme Court has established that laws of nature, natural phenomena, and abstract ideas are not patentable. The two-step test from the Alice decision is commonly used to determine if a claim is directed to an abstract idea and whether it provides an inventive step that transforms the abstract idea into a patent-eligible invention[4].

The 2024 USPTO Guidance Update on AI Patents

Recent updates from the USPTO, particularly the 2024 guidance on AI-related inventions, provide valuable insights. This guidance emphasizes the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must impose meaningful limits on the exception, demonstrating a concrete technological improvement. This is particularly relevant for AI-assisted inventions, where the method of invention development does not impact subject matter eligibility, but the claimed invention itself must show significant human contribution and practical application[1].

Claim Scope and Drafting

The scope of the claims is vital in a patent application. While broader claims may seem appealing for broader protection, they are often more difficult to get granted and easier to invalidate. Claims must be anchored to the embodiments disclosed in the specification and should avoid being overly broad to prevent invalidation grounds such as the abstract idea exception and failure to meet the written description requirement[5].

Analyzing the Claims of Patent 11,993,605

Claim Structure

To analyze the claims of Patent 11,993,605, one must examine the claim structure. This includes identifying independent and dependent claims, understanding the elements of each claim, and how they relate to the specification.

Practical Applications

Each claim must be evaluated to see if it integrates abstract ideas into practical applications. For example, if the patent involves AI technology, the claims should specify how the AI is used in a real-world application, such as improving speech recognition or enhancing data processing, to demonstrate tangible benefits and technological improvements[1].

Comparison with Prior Art

The claims must also be compared against prior art to ensure novelty and non-obviousness. A thorough prior art search using the USPTO's patent database or other resources is essential to determine if the invention has already been patented or described in a publication[2].

Case Law and Precedents

Recent court decisions, such as Broadband iTV, Inc. v. Amazon.com, Inc., highlight the importance of ensuring that claims are not directed to abstract ideas without an inventive step. The Federal Circuit has consistently affirmed that claims must provide a meaningful limit and integrate the judicial exception into a practical application to be patent-eligible[4].

Patent Landscape and Industry Impact

Understanding the patent landscape involves looking at the broader technological field and how the patent fits within it. For AI-related patents, the landscape is rapidly evolving, with a focus on ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This includes considering the role of AI as a tool and ensuring significant human contribution to the claimed invention[1].

Key Takeaways

  • Subject Matter Eligibility: Ensure that claims integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • Claim Scope: Balance between broad and narrow claims, ensuring they are anchored to the specification and avoid being overly broad.
  • Practical Applications: Highlight real-world applications of the claimed method or system to demonstrate tangible benefits.
  • Prior Art: Conduct thorough searches to ensure novelty and non-obviousness.
  • Case Law: Align claims with recent court decisions to avoid common pitfalls such as abstract idea exceptions.

FAQs

  1. What is the significance of the 2024 USPTO guidance update on AI patents? The update clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring AI-assisted inventions are evaluated on equal footing with other technologies[1].

  2. Why is claim scope important in a patent application? Claim scope is crucial because it defines the scope of the patent's protection. While broader claims may offer broader protection, they are more difficult to get granted and easier to invalidate. Claims must be balanced and anchored to the specification[5].

  3. How do recent court decisions impact patent claims? Recent court decisions, such as Broadband iTV, Inc. v. Amazon.com, Inc., emphasize that claims must not be directed to abstract ideas without an inventive step. Claims must provide a meaningful limit and integrate the judicial exception into a practical application to be patent-eligible[4].

  4. What is the role of prior art in patent applications? Prior art is essential in determining the novelty and non-obviousness of an invention. A thorough prior art search helps ensure that the invention has not already been patented or described in a publication[2].

  5. How does the patent landscape affect AI-related patents? The patent landscape for AI-related patents is evolving, with a focus on ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This includes considering the role of AI as a tool and ensuring significant human contribution to the claimed invention[1].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent
    • Mintz, Understanding the 2024 USPTO Guidance Update on AI Patent, July 25, 2024.
  2. Patents | The Maryland People's Law Library
    • Maryland People's Law Library, Patents, July 9, 2024.
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
    • SSRN, Patent Claims and Patent Scope, September 29, 2016.
  4. BROADBAND ITV, INC. v. AMAZON.COM, INC.
    • United States Court of Appeals for the Federal Circuit, Broadband iTV, Inc. v. Amazon.com, Inc., September 3, 2024.
  5. The Importance of Getting the Claim Scope Right in a US Patent Application
    • Rimon Law, The Importance of Getting the Claim Scope Right in a US Patent Application, October 4, 2021.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,993,605

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-001 Aug 16, 2019 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF ADULTS WITH ACTIVE PSORIATIC ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS ⤷  Try for Free
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-001 Aug 16, 2019 RX Yes No ⤷  Try for Free ⤷  Try for Free TREATMENT OF PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER WITH ACTIVE PSORIATIC ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 2 of 2 entries

International Family Members for US Patent 11,993,605

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2016340167 ⤷  Try for Free
Australia 2020359635 ⤷  Try for Free
Australia 2021236570 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.